Marshall & Sullivan Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SCHW
Charles Schwab
SCHW
|
+$6.03M |
| 2 |
Lam Research
LRCX
|
+$4.34M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$605K |
| 4 |
Apple
AAPL
|
+$289K |
| 5 |
Becton Dickinson
BDX
|
+$238K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$675K |
| 2 |
Danaher
DHR
|
+$626K |
| 3 |
Meta Platforms (Facebook)
META
|
+$469K |
| 4 |
Walt Disney
DIS
|
+$202K |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$96.5K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.78% |
| 2 | Technology | 18.1% |
| 3 | Consumer Discretionary | 13.03% |
| 4 | Financials | 8.55% |
| 5 | Communication Services | 8.06% |
Similar funds
Marshall & Sullivan's Q3 2021 Portfolio in Review
As of Q3 2021, Marshall & Sullivan held 41 positions worth $192M, up 6.3% from $180M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Marshall & Sullivan deployed $12M of net new capital in Q3 2021, opening 2 new positions and adding to 24 existing holdings. Its largest new stake was Charles Schwab: 84,439 shares worth $6.15M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 20% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class A, an estimated $675K trimmed.
- Marshall & Sullivan's largest Q3 2021 buy was Charles Schwab: 84,439 shares worth $6.15M.
- Marshall & Sullivan added most to iShares Russell 2000 ETF in Q3 2021, an estimated $605K increase.
- Marshall & Sullivan's biggest Q3 2021 reduction was Alphabet (Google) Class A, cutting an estimated $675K.
- Marshall & Sullivan fully exited Walt Disney in Q3 2021, selling an estimated $202K.
- Marshall & Sullivan's ten largest holdings make up 48% of its $192M portfolio in Q3 2021.
- Marshall & Sullivan opened 2 new positions and closed 1 in Q3 2021.
- Marshall & Sullivan's portfolio value rose 6.3% quarter-over-quarter to $192M.
Based on Marshall & Sullivan's 13F filing for Q3 2021, filed 19 Oct 2021.